Business Wire

ATNI

1.7.2021 09:02:13 CEST | Business Wire | Press release

Share
Global Access to Nutrition Index 2021 Calls for Food Industry to Urgently Address Nutrition Gap in the COVID-19 Era

Access to Nutrition Initiative (ATNI) has launched its 2021 Global Index, assessing the world’s 25 largest global food and beverage manufacturers and their contributions to addressing malnutrition. While some companies have shown significant progress since it’s last iteration in 2018, progress from the top 10 ranking manufacturers has slowed. ATNI is urgently calling on companies to step up efforts to tackle some of the world’s toughest nutrition challenges.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210701005100/en/

Malnutrition in any form affects every county in the world, contributing towards millions of deaths and people at risk of diet related diseases. In 2019, 690 million people (8.9% of the global population) were considered undernourished, and with the economic effects of COVID-19 we’re seeing even more people experiencing extreme poverty and the consequences of overweight and diet-related diseases.

FCDO Minister for the European Neighbourhood and the Americas, Wendy Morton said: “We welcome the launch of this year’s Index, particularly as COVID-19 has worsened levels of malnutrition and the availability of food globally. We have a unique opportunity to address this in ways that benefit everyone. We must hold the world’s biggest food and beverage companies to account to help speed up our global recovery from the pandemic.”

Inge Kauer, Executive Director of ATNI, added, As the 25 largest food and beverage manufacturers, each must take responsibility to deliver healthy product offerings to consumers across the globe and not leave nutrition behind. That’s no small task – but it’s one that requires action urgently if we are to deliver on the Sustainable Development Goals to end world hunger and ensure good health and well-being.”

Highlights and Rankings

All companies were assessed on their commitments, practices, and disclosure – with regards to governance and management, the production and distribution of healthy, affordable, accessible products, and how companies influence consumer choices and behavior.

  • The average score remained the same as 2018: 3.3/10.
    • Nestlé led the 2021 ranking with a score of 6.7. The company achieved a top-3 rank in all categories and ranked first on ‘Governance’, and ‘Engagement’.
    • Unilever came second with 6.3, and FrieslandCampina third with 5.9.
    • Arla showed a big improvement from 3.3 in 2018 to 5.1 in 2021, largely because of a new labeling policy, responsible marketing policies, and an improvement in healthiness of its product portfolio.
    • Meiji rose four places, partially due to incorporation of a nutrition strategy in its CSR vision and new policies aimed at marketing to children and labeling.
  • Only 31% of products met the independent health standard (a health star rating of 3.5 stars or more ). This equates to 11,797 of the 38,176 distinct products sold by the 25 companies globally
    • Just five companies were found to have half or more of their products meet the healthy threshold of 3.5 stars
    • Nine companies improved the average HSR of their products between 2018 and 2021.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

RevolKa Reimagines Antibody Engineering with "RevoAb®"1.4.2026 06:30:00 CEST | Press release

A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allo

Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press release

Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales,

bet365 Partners with TestMu AI to Accelerate Global Release Velocity with Agentic AI Quality Engineering31.3.2026 19:01:00 CEST | Press release

Streamlines Hillside Technology testing across browsers and mobile devices while supporting rapid expansion into regulated markets. TestMu AI (Formerly LambdaTest), the world's first full-stack Agentic AI Quality Engineering platform, today announced that Hillside Technology Limited, the technology powerhouse behind global online gambling leader bet365, has adopted its platform to unify software testing and support hundreds of weekly production releases. The global online gaming industry is currently experiencing a massive shift, with the market projected to exceed $150 billion by 2030. As mobile gaming becomes the primary touchpoint for users, the technical complexity of delivering a seamless, low-latency experience has grown exponentially. For industry giants like bet365, the need to validate software across an infinite matrix of hardware, screen resolutions, and OS versions is a mission-critical requirement. This partnership ensures that, as gaming becomes more mobile-centric, bet36

IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand31.3.2026 16:00:00 CEST | Press release

Regulatory milestone opens heart health growth opportunities for food and beverage manufacturers IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and health & biosciences announced today that a new heart health claim for isolated soy protein has been accepted by the Food Standards Australia New Zealand (FSANZ). The approval enables food and beverage manufacturers in Australia and New Zealand to link soy protein consumption with healthy blood cholesterol levels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330523416/en/ First heart health claim approved for soy protein in Australia and New Zealand. “For decades, IFF has invested in the science behind soy protein and its role in supporting cardiovascular health,” said Tony Andrew, vice president of protein solutions for IFF Food Ingredients. “This approved claim validates years of rigorous research and collaboration. With our deep expertise in ing

Sub-Q Bionics Closes $1.5M Pre-Seed Round to Advance Next-Generation Solution for Lymphedema Care31.3.2026 15:26:00 CEST | Press release

Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5 million pre-seed funding round. The round includes investment from Mayo Clinic and Yeda, the technology transfer company of the Weizmann Institute of Science, as well as several private investors. The Israel Innovation Authority also provided matching funds. The funding will enable Sub-Q Bionics to continue to develop its novel bionic lymph node technology designed to transform how lymphedema is managed, based on scientific innovations from the Weizmann Institute and Shamir Medical Center. The system aims to provide a solution to manage fluid with a subcutaneous implant that will allow patients freedom of movement, automatic fluid management and reduction of symptoms such as pain and swelling. Lymphedema affects millions of patients worldwide, especially breast cancer survivors, and remains significantly under

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye